Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment
The mitochondrion is an important intracellular organelle for drug targeting due to its key roles and functions in cellular proliferation and death. In the last few decades, several studies have revealed mitochondrial functions, attracting the focus of many researchers to work in this field over nuc...
Saved in:
Main Authors: | Gantumur Battogtokh (Author), Yong-Yeon Cho (Author), Joo Young Lee (Author), Hye Suk Lee (Author), Han Chang Kang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives
by: Gantumur Battogtokh, et al.
Published: (2018) -
Pharmaceutical Aspects of Nanocarriers for Smart Anticancer Therapy
by: Seung Rim Hwang, et al.
Published: (2021) -
New Properties and Mitochondrial Targets of Polyphenol Agrimoniin as a Natural Anticancer and Preventive Agent
by: Tatiana A. Fedotcheva, et al.
Published: (2021) -
Designing of the Anticancer Nanocomposite with Sustained Release Properties by Using Graphene Oxide Nanocarrier with Phenethyl Isothiocyanate as Anticancer Agent
by: Dasan Mary Jaya Seema, et al.
Published: (2018) -
RIG-I Deficiency Promotes Obesity-Induced Insulin Resistance
by: Gabsik Yang, et al.
Published: (2021)